Pharma-Bio Serv, Inc. (PBSV)
- Previous Close
0.7498 - Open
0.6501 - Bid --
- Ask --
- Day's Range
0.6500 - 0.7130 - 52 Week Range
0.6500 - 1.1000 - Volume
2,221 - Avg. Volume
2,288 - Market Cap (intraday)
16.372M - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
23.77 - EPS (TTM)
0.0300 - Earnings Date Jun 12, 2024 - Jun 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jan 29, 2024
- 1y Target Est
1.70
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
www.pharmabioserv.com100
Full Time Employees
October 31
Fiscal Year Ends
Sector
Industry
Recent News: PBSV
Performance Overview: PBSV
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PBSV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PBSV
Valuation Measures
Market Cap
17.22M
Enterprise Value
1.64M
Trailing P/E
28.84
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.14
Price/Book (mrq)
1.22
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
4.05%
Return on Assets (ttm)
1.09%
Return on Equity (ttm)
3.94%
Revenue (ttm)
15.12M
Net Income Avi to Common (ttm)
613.03k
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
15.89M
Total Debt/Equity (mrq)
2.19%
Levered Free Cash Flow (ttm)
4.04M
Research Analysis: PBSV
Company Insights: PBSV
PBSV does not have Company Insights